Why the study?
The association of the atherogenic index of plasma with adverse outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome undergoing PCI was not determined.
Does a higher atherogenic index of plasma predict adverse cardiovascular events in T2DM patients with ACS undergoing PCI?
Does a higher atherogenic index of plasma predict adverse cardiovascular events in T2DM patients with ACS undergoing PCI?
A higher atherogenic index of plasma on admission is independently associated with an increased risk of adverse cardiovascular events in T2DM patients with ACS undergoing PCI.
No takes yet. Share an insight, caveat, or question.
May aid risk stratification in T2DM-ACS-PCI; leaves open whether AIP modification improves outcomes.
Ma et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: